Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
Monitoring neuromyelitis optica activity.
Multiple sclerosis and herpesvirus interaction.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Diagnosis and classification of autoimmune optic neuropathy.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Concepts for regulation of axon integrity by enwrapping glia.
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis.
[Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis.]
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Defining the new end point for multiple sclerosis treatment.
CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.
Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse.
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Fluctuations of MS births and UV-light exposure.
The Gut Microbiome and the Brain.
Small and Long Regulatory RNAs in the Immune System and Immune Diseases.
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Beneficial effects of Rituximab in patients with anti-MAG (myelin-associated glycoprotein) neuropathy: case reports.

Pages